Ionis Pharmaceuticals

+$1.54 (+5.11%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.

About IONS

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments.

CEO
Brett P. Monia
Employees
757
Headquarters
Carlsbad, California
Founded
1989

IONS Key Statistics

Market cap
4.47B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.49M
High today
$31.70
Low today
$29.87
Open price
$30.04
Volume
827.44K
52 Week high
$62.65
52 Week low
$25.04

IONS News

MarketWatchJan 24

Ionis, AstraZeneca Get FDA Orphan Designation for Eplontersen

By Colin Kellaher Ionis Pharmaceuticals Inc. and AstraZeneca PLC on Monday said the U.S. Food and Drug Administration granted orphan-drug designation to their

IONS Earnings

-$0.58
-$0.12
$0.35
$0.81
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure